Nicotinell Mint Spray Buccal

Nicotine, the active ingredient in Nicotinell Mint Spray Buccal, is a nicotine replacement therapy presented as a buccal spray for oromucosal use. It helps adult smokers who wish to quit by reducing nicotine withdrawal symptoms and cravings associated with cigarette dependence. The product is marketed in the European Union and is formulated to deliver a rapid, controlled dose of nicotine through the oral mucosa.

GNH USA supplies Nicotinell Mint Spray Buccal as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Mint Spray Buccal is a nicotine replacement therapy used in smoking cessation.

- Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms while transitioning away from cigarettes. - Tobacco dependence: provides a controlled nicotine dose to support gradual reduction of tobacco use. - Relapse prevention: can be used after quitting to manage occasional urges and maintain abstinence.

Common Side Effects: - Mouth irritation or tingling sensation. - Throat discomfort or mild cough. - Nausea or upset stomach. - Headache or light‑headedness. - Dizziness or transient fatigue.

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling, or difficulty breathing. - Significant increase in blood pressure or heart rate. - Cardiac arrhythmias or chest pain. - Severe oral ulceration or bleeding. - Persistent vomiting or severe nausea.

Before using Nicotinell Mint Spray Buccal, consider the following precautions: - Not for use by non‑smokers or former smokers who have been abstinent for more than 30 days. - Avoid if you have uncontrolled hypertension or recent cardiovascular events. - Use only as directed; do not exceed the prescribed number of sprays. - Pregnancy and breastfeeding safety have not been established; consult a healthcare professional. - Keep out of reach of children and pets. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nicotinell Mint Spray Buccal may interact with other substances that affect nicotine metabolism or cardiovascular function.

Major Interactions (Avoid): - Concurrent use of other nicotine‑containing products (e.g., patches, gum) may lead to nicotine overdose. - Use with monoamine oxidase inhibitors (MAOIs) can increase the risk of hypertensive episodes.

Moderate Interactions (Monitor Closely): - Bupropion or varenicline may enhance nicotine‑related side effects. - Certain antihypertensive medications may have reduced efficacy. - High caffeine intake can exacerbate nervous system stimulation.